nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pillar of Brazilian public health: Fiocruz at 125
|
Alves, Lise |
|
|
405 |
10492 |
p. 1805-1806 |
artikel |
2 |
Asymptomatic tuberculosis: undetected and underestimated, but not unimportant
|
Dheda, Keertan |
|
|
405 |
10492 |
p. 1797-1800 |
artikel |
3 |
Can Somalia avert a food security catastrophe?
|
Jamil, Safayet |
|
|
405 |
10492 |
p. 1814 |
artikel |
4 |
Decentralising clinical trial access requires a culture of health equity
|
Sabesan, Sabe |
|
|
405 |
10492 |
p. 1816 |
artikel |
5 |
Department of Error
|
|
|
|
405 |
10492 |
p. 1816 |
artikel |
6 |
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
|
Bensimon, Gilbert |
|
|
405 |
10492 |
p. 1837-1850 |
artikel |
7 |
Examining the evidence for IL-2 in amyotrophic lateral sclerosis
|
Benatar, Michael |
|
|
405 |
10492 |
p. 1793-1795 |
artikel |
8 |
Freezing of USAID: a health crisis for India's transgender community
|
Banerjee, Shashwat S |
|
|
405 |
10492 |
p. 1813-1814 |
artikel |
9 |
Gaza has been failed by silence and impunity
|
The Lancet, |
|
|
405 |
10492 |
p. 1791 |
artikel |
10 |
Guatemala's resolution on kidney health: a historic opportunity
|
Tonelli, Marcello |
|
|
405 |
10492 |
p. 1809-1810 |
artikel |
11 |
Improved hypertension care requires measurement and management in health facilities, not mass screening
|
Frieden, Thomas R |
|
|
405 |
10492 |
p. 1879-1882 |
artikel |
12 |
Logistics of the malaria vaccine roll-out in Nigeria
|
Atere, Ahmad Olawale |
|
|
405 |
10492 |
p. 1815 |
artikel |
13 |
Mapping the unseen: global prevalence of childhood sexual violence
|
Letourneau, Elizabeth J |
|
|
405 |
10492 |
p. 1792-1793 |
artikel |
14 |
Nivolumab plus ipilimumab in hepatocellular carcinoma
|
Vithayathil, Mathew |
|
|
405 |
10492 |
p. 1795-1797 |
artikel |
15 |
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial
|
Yau, Thomas |
|
|
405 |
10492 |
p. 1851-1864 |
artikel |
16 |
Prevalence of sexual violence against children and age at first exposure: a global analysis by location, age, and sex (1990–2023)
|
Cagney, Jack |
|
|
405 |
10492 |
p. 1817-1836 |
artikel |
17 |
Reducing the burden of chronic kidney disease in the world
|
Lou-Meda, Randall |
|
|
405 |
10492 |
p. 1810 |
artikel |
18 |
Regulatory asymmetry in Alzheimer's disease care
|
Fortea, Juan |
|
|
405 |
10492 |
p. 1812-1813 |
artikel |
19 |
Relieve the suffering: palliative care for the next decade
|
Rosa, William E |
|
|
405 |
10492 |
p. 1802-1804 |
artikel |
20 |
The final 20 years of the Gates Foundation
|
Samarasekera, Udani |
|
|
405 |
10492 |
p. 1807-1808 |
artikel |
21 |
The promise and compromise of the WHO Pandemic Agreement for spillover prevention and One Health
|
Finch, Alexandra |
|
|
405 |
10492 |
p. 1800-1802 |
artikel |
22 |
The regulatory rollercoaster continues—EMA refuses donanemab
|
De Strooper, Bart |
|
|
405 |
10492 |
p. 1810-1812 |
artikel |
23 |
Trachoma
|
Habtamu, Esmael |
|
|
405 |
10492 |
p. 1865-1878 |
artikel |